Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01SC009144-13
Application #
6163334
Study Section
Special Emphasis Panel (LP)
Project Start
Project End
Budget Start
Budget End
Support Year
13
Fiscal Year
1997
Total Cost
Indirect Cost
Name
National Cancer Institute Division of Clinical Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Levens, David (2010) You Don't Muck with MYC. Genes Cancer 1:547-554
Kouzine, Fedor; Sanford, Suzanne; Elisha-Feil, Zichrini et al. (2008) The functional response of upstream DNA to dynamic supercoiling in vivo. Nat Struct Mol Biol 15:146-54
Kouzine, Fedor; Levens, David (2007) Supercoil-driven DNA structures regulate genetic transactions. Front Biosci 12:4409-23
Liu, Juhong; Kouzine, Fedor; Nie, Zuqin et al. (2006) The FUSE/FBP/FIR/TFIIH system is a molecular machine programming a pulse of c-myc expression. EMBO J 25:2119-30
Matsushita, Kazuyuki; Tomonaga, Takeshi; Shimada, Hideaki et al. (2006) An essential role of alternative splicing of c-myc suppressor FUSE-binding protein-interacting repressor in carcinogenesis. Cancer Res 66:1409-17
Weber, Achim; Gutierrez, Marina I; Levens, David (2006) The CT-element of the c-myc gene does not predispose to chromosomal breakpoints in Burkitt's lymphoma. Cell Oncol 28:31-5
Chung, Hye-Jung; Liu, Juhong; Dundr, Miroslav et al. (2006) FBPs are calibrated molecular tools to adjust gene expression. Mol Cell Biol 26:6584-97
Liu, J; Levens, D (2006) Making myc. Curr Top Microbiol Immunol 302:1-32
Weber, Achim; Liu, Juhong; Collins, Irene et al. (2005) TFIIH operates through an expanded proximal promoter to fine-tune c-myc expression. Mol Cell Biol 25:147-61
Huth, Jeffrey R; Yu, Liping; Collins, Irene et al. (2004) NMR-driven discovery of benzoylanthranilic acid inhibitors of far upstream element binding protein binding to the human oncogene c-myc promoter. J Med Chem 47:4851-7

Showing the most recent 10 out of 11 publications